Dashboard
Manage Tickers

REGNREGENERON PHARMACEUTICALS, ...

Nasdaq regeneron.com


$ 1,072.36 $ -10.91 (-1.01 %)    

Monday, 05-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 437.97 $ -13.38 (-2.98 %)
DIA $ 386.91 $ -10.32 (-2.6 %)
SPY $ 518.58 $ -15.52 (-2.91 %)
TLT $ 98.76 $ 0.52 (0.53 %)
GLD $ 222.59 $ -2.86 (-1.27 %)
$ 1071.28
$ 1,071.28 x 100
-- x --
-- - --
$ 765.28 - $ 1,115.00
611,161
na
123.63B
$ 0.54
$ 28.61
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-05-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-06-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-07-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-08-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-07-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 02-07-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-08-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 11-04-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 02-11-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-04-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 02-12-2015 12-31-2014 10-K
40 11-04-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-regeneron-pharmaceuticals-raises-price-target-to-1200
JP Morgan Maintains Overweight on Regenero...
08/02/2024 20:48:25

JP Morgan analyst Chris Schott maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price targ...

rbc-capital-maintains-outperform-on-regeneron-pharmaceuticals-raises-price-target-to-1240
RBC Capital Maintains Outperform on Regene...
08/02/2024 20:36:15

RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and raises the price ...

guggenheim-maintains-buy-on-regeneron-pharmaceuticals-raises-price-target-to-1300
Guggenheim Maintains Buy on Regeneron Phar...
08/02/2024 19:14:58

Guggenheim analyst Yatin Suneja maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target fro...

wells-fargo-maintains-overweight-on-regeneron-pharmaceuticals-raises-price-target-to-1200
Wells Fargo Maintains Overweight on Regene...
08/02/2024 18:29:51

Wells Fargo analyst Mohit Bansal maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price ta...

barclays-maintains-overweight-on-regeneron-pharmaceuticals-raises-price-target-to-1220
Barclays Maintains Overweight on Regeneron...
08/02/2024 15:32:32

Barclays analyst Carter Gould maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price targe...

analyst-ratings-for-regeneron-pharmaceuticals
Analyst Ratings For Regeneron Pharmaceuticals
08/02/2024 14:01:18

truist-securities-reiterates-buy-on-regeneron-pharmaceuticals-raises-price-target-to-1200
Truist Securities Reiterates Buy on Regene...
08/02/2024 13:21:59

Truist Securities analyst Srikripa Devarakonda reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the ...

regeneron-pharmaceuticals-q2-earnings-exceed-estimates-driven-by-its-top-selling-eczema-and-eye-drugs
Regeneron Pharmaceuticals' Q2 Earnings Exc...
08/01/2024 17:23:58

Regeneron Pharmaceuticals Q2 results: adjusted EPS of $11.56 (up 13%), revenue of $3.55 billion (up 12%). Key drivers: Eylea HD...

us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday
US Stocks Tumble On Economic, Geopolitical...
08/01/2024 17:11:53

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november
Wall Street Looks To Ride On Earnings Chee...
08/01/2024 11:35:52

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

regeneron-pharmaceuticals-q2-2024-adj-eps-1156-beats-1061-estimate-sales-355b-beat-338b-estimate
Regeneron Pharmaceuticals Q2 2024 Adj EPS ...
08/01/2024 10:33:37

Regeneron Pharmaceuticals (NASDAQ:REGN) reported quarterly earnings of $11.56 per share which beat the analyst consensus estima...

exploring-the-competitive-space-regeneron-pharmaceuticals-versus-industry-peers-in-biotechnology
Exploring The Competitive Space: Regeneron...
07/30/2024 15:00:33

apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings
Apple, Amazon, Microsoft, Meta Lead The Ch...
07/29/2024 10:25:11

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

sanofi-raises-2024-profit-outlook-on-strong-q2-earnings-blockbuster-drug-dupixent-sees-strong-demand
Sanofi Raises 2024 Profit Outlook On Stron...
07/25/2024 12:20:12

Sanofi reports a 7.8% YoY sales increase in Q2, with sales reaching $11.57 billion, beating consensus. Key highlights include a...

td-cowen-maintains-buy-on-regeneron-pharmaceuticals-raises-price-target-to-1200
TD Cowen Maintains Buy on Regeneron Pharma...
07/23/2024 17:01:18

TD Cowen analyst Tyler Van Buren maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target fr...

maia-biotechnologys-lung-cancer-drug-shows-promising-long-term-benefits-in-advanced-patients
MAIA Biotechnology's Lung Cancer Drug Show...
07/23/2024 14:38:11

MAIA Biotechnology's Phase 2 THIO-101 trial shows promising updates for THIO with Regeneron's cemiplimab in advanced NS...

100-invested-in-this-stock-15-years-ago-would-be-worth-5100-today
$100 Invested In This Stock 15 Years Ago W...
07/22/2024 19:00:23

cantor-fitzgerald-maintains-neutral-on-regeneron-pharmaceuticals-raises-price-target-to-1000
Cantor Fitzgerald Maintains Neutral on Reg...
07/22/2024 15:33:21

Cantor Fitzgerald analyst Olivia Brayer maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and raises the pric...

peering-into-regeneron-pharmaceuticalss-recent-short-interest
Peering Into Regeneron Pharmaceuticals's R...
07/19/2024 16:00:14

piper-sandler-maintains-overweight-on-regeneron-pharmaceuticals-raises-price-target-to-1166
Piper Sandler Maintains Overweight on Rege...
07/19/2024 12:17:35

Piper Sandler analyst Christopher Raymond maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION